GALNT3 is an enzyme for O-glycosylation, and down-regulation of GALNT3 has been reported to be associated with poor prognosis of lung adenocarcinoma [40], colorectal cancer [41], and pancreatic cancer [42, 43]. Here, GALNT3 is linked to lung adenocarcinoma.